Bailey Megan D.

Bailey Megan D., EVP and Chief Strategy Officer, has demonstrated a consistent pattern of selling activity in her transactions involving Laboratory Corporation of America Holdings (LH), as disclosed in SEC Form 4 filings. Over 34 reported trades, Bailey has exclusively engaged in selling, with no recorded purchases, resulting in a total sell value of $724,197.61. Her activity is concentrated solely on LH, indicating a focused approach to divesting her holdings in this single company. Recent filings highlight a continuation of this trend, with notable transactions occurring between February 2025 and March 2026. On March 26, 2026, Bailey executed a sale valued at $129,090.78, marking one of the larger transactions in this period. Earlier in February 2026, she conducted multiple sales, including transactions worth $40,004.82 on February 11 and $23,290.85 on February 9. Additionally, a significant sale of $359,676.90 was recorded on April 1, 2025, underscoring her sustained divestment strategy. Smaller transactions, such as $5,417.94 on February 7, 2025, and $17,341.80 on February 6, 2025, further illustrate her consistent selling activity. Bailey’s trading pattern reveals a clear bias toward reducing her stake in LH, with no indication of acquiring additional shares. The absence of buying activity and the regularity of sales suggest a deliberate approach to managing her equity position in the company. This data, derived from SEC filings, provides a transparent view of her insider trading behavior without implying any underlying motives or access to material non-public information.